RSS   Newsletter   Contact   Advertise with us
Post Online Media

Biocept names VP, strategy & corporate communications

BioceptBiocept, a molecular diagnostics company, announces the appointment of David Moskowitz to the newly created position of vice president, strategy and corporate communications.
Article continues below

READ MORE Biocept appoints Michael Terry SVP, commercial operations

Most recently, Mr. Moskowitz was Vice President, Investor Relations at Trovagene, a publicly traded molecular diagnostics company.

He previously was on Wall Street and served as Director of Equity Research at Caris & Co. and as Head of Healthcare Research at Friedman Billings Ramsey.

During his tenure in the financial services industry, Mr. Moskowitz also held analyst positions at UBS Warburg and Roth Capital Partners. In 2011, he received the StarMine Analyst Award as the top stock picker among U.S. Biotechnology Analysts.

Mr. Moskowitz has also performed strategic advisory work and capital markets planning for several emerging biopharmaceutical and molecular diagnostics companies.

He earned his BS in Pharmacy from Rutgers University and his MBA in Finance and Pharmaceutical Industry Studies at Fairleigh Dickinson University.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy